Arrowhead Pharmaceuticals, Inc.ARWRNASDAQ
Loading
EBITDA Over TimeExpanding
Percentile Rank100
Studio
Year-over-Year Change

Earnings before interest, taxes, depreciation, and amortization

Latest
$370.22M
↑ 715% vs avg
Percentile
P100
Near historical high
Streak
2 yr
Consecutive growthExpanding
Average
$-60.21M
Historical baseline
PeriodValueYoY Change
TTM$370.22M+124.6%
2025$164.82M+129.4%
2024$-561.51M-219.6%
2023$-175.67M-8.2%
2022$-162.29M-22.4%
2021$-132.58M-52.0%
2020$-87.22M-232.9%
2019$65.63M+228.1%
2018$-51.24M-58.6%
2017$-32.31M-